• Miscellaneous dermatological conditions

Qbrexza Generic Name & Formulations

General Description

Glycopyrronium 2.4% soln; per cloth (pre-moistened).

Pharmacological Class


How Supplied

Single-use cloth—30

Generic Availability


Qbrexza Indications


Primary axillary hyperhidrosis.

Qbrexza Dosage and Administration

Adults and Children

<9yrs: not established. ≥9yrs: Using a single cloth, apply once daily to both axillae. Do not occlude.

Qbrexza Contraindications


Conditions that can be exacerbated by anticholinergic effect (eg, glaucoma, paralytic ileus, unstable cardiovascular status in acute hemorrhage, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis, myasthenia gravis, Sjogren's syndrome).

Qbrexza Boxed Warnings

Not Applicable

Qbrexza Warnings/Precautions


History of documented urinary retention. Discontinue immediately if symptoms of urinary retention develop. Prostatic hypertrophy or bladder-neck obstruction. High ambient temperature. Advise patients to avoid use if generalized lack of sweating develops when exposed to hot/warm temperatures. Avoid other body areas, broken skin, contact with the eyes, or transfer to the periocular area. Flammable. Renal impairment. Pregnancy. Nursing mothers.

Qbrexza Pharmacokinetics

See Literature

Qbrexza Interactions


Additive anticholinergic effects with other anticholinergic-containing drugs; avoid.

Qbrexza Adverse Reactions

Adverse Reactions

Dry mouth, mydriasis, oropharyngeal pain, headache, urinary hesitation, vision blurred, nasal dryness, dry throat/eye/skin, constipation, local skin reactions (eg, erythema, burning/stinging/pruritus).

Qbrexza Clinical Trials

See Literature

Qbrexza Note

Not Applicable

Qbrexza Patient Counseling

See Literature